Published in Infect Immun on January 25, 2010
Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood. PLoS Pathog (2011) 1.57
Molecular mechanisms of complement evasion: learning from staphylococci and meningococci. Nat Rev Microbiol (2010) 1.52
Genetic elimination of the binding motif on fibrinogen for the S. aureus virulence factor ClfA improves host survival in septicemia. Blood (2013) 1.03
Subterfuge and sabotage: evasion of host innate defenses by invasive gram-positive bacterial pathogens. Annu Rev Microbiol (2014) 1.00
Staphylococcus aureus surface protein SdrE binds complement regulator factor H as an immune evasion tactic. PLoS One (2012) 0.97
Development of a multicomponent Staphylococcus aureus vaccine designed to counter multiple bacterial virulence factors. Hum Vaccin Immunother (2012) 0.96
A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposure. Clin Vaccine Immunol (2012) 0.95
Multiple activities of LigB potentiate virulence of Leptospira interrogans: inhibition of alternative and classical pathways of complement. PLoS One (2012) 0.91
Exploring Staphylococcus aureus pathways to disease for vaccine development. Semin Immunopathol (2011) 0.90
Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus. J Transl Med (2012) 0.90
Antimicrobial Mechanisms of Macrophages and the Immune Evasion Strategies of Staphylococcus aureus. Pathogens (2015) 0.85
Pathogenesis of Staphylococcus aureus Bloodstream Infections. Annu Rev Pathol (2016) 0.83
Complement Effectors of Inflammation in Cystic Fibrosis Lung Fluid Correlate with Clinical Measures of Disease. PLoS One (2015) 0.83
Disruption of the alternative pathway convertase occurs at the staphylococcal surface via the acquisition of factor H by Staphylococcus aureus. Mol Immunol (2010) 0.81
Immunomodulation and Disease Tolerance to Staphylococcus aureus. Pathogens (2015) 0.80
Acquisition of complement inhibitor serine protease factor I and its cofactors C4b-binding protein and factor H by Prevotella intermedia. PLoS One (2012) 0.80
Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection. MBio (2016) 0.80
Molecular Characterization of the Multiple Interactions of SpsD, a Surface Protein from Staphylococcus pseudintermedius, with Host Extracellular Matrix Proteins. PLoS One (2013) 0.79
Streptococcus pyogenes Employs Strain-dependent Mechanisms of C3b Inactivation to Inhibit Phagocytosis and Killing of Bacteria. J Biol Chem (2016) 0.79
Staphylococcus aureus - antimicrobial resistance and the immunocompromised child. Infect Drug Resist (2014) 0.78
Hyperglycemia inhibits complement-mediated immunological control of S. aureus in a rat model of peritonitis. J Diabetes Res (2014) 0.78
Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease. MBio (2016) 0.77
New potential role of serum apolipoprotein E mediated by its binding to clumping factor A during Staphylococcus aureus invasive infections to humans. J Med Microbiol (2015) 0.76
Inhibition of Myeloperoxidase Activity in Cystic Fibrosis Sputum by Peptide Inhibitor of Complement C1 (PIC1). PLoS One (2017) 0.75
Fibrinogen Is at the Interface of Host Defense and Pathogen Virulence in Staphylococcus aureus Infection. Semin Thromb Hemost (2016) 0.75
Staphylococcus aureus Aggregation and Coagulation Mechanisms, and Their Function in Host-Pathogen Interactions. Adv Appl Microbiol (2016) 0.75
Serine-aspartate-repeat protein D Increases Staphylococcus aureus Virulence and Survival in Blood. Infect Immun (2016) 0.75
Lessons from the Crystal Structure of the S. aureus Surface Protein Clumping Factor A in Complex With Tefibazumab, an Inhibiting Monoclonal Antibody. EBioMedicine (2016) 0.75
Contribution of Staphylococcus aureus Coagulases and Clumping Factor A to Abscess Formation in a Rabbit Model of Skin and Soft Tissue Infection. PLoS One (2016) 0.75
Neutrophils and Immunity: From Bactericidal Action to Being Conquered. J Immunol Res (2017) 0.75
Clumping factor A of Staphylococcus aureus interacts with AnnexinA2 on mammary epithelial cells. Sci Rep (2017) 0.75
Multi-functional mechanisms of immune evasion by the streptococcal complement inhibitor C5a peptidase. PLoS Pathog (2017) 0.75
Multi-mechanistic monoclonal antibodies targeting S. aureus α-toxin and clumping factor A: Activity and efficacy comparisons of a mAb combination and an engineered bispecific antibody approach. Antimicrob Agents Chemother (2017) 0.75
The remarkably multifunctional fibronectin binding proteins of Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (2016) 0.75
Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA (2007) 26.98
Staphylococcal coagulase; mode of action and antigenicity. J Gen Microbiol (1952) 8.13
Complement evasion by human pathogens. Nat Rev Microbiol (2008) 4.24
Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun (1995) 3.65
The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages. J Bacteriol (2006) 3.50
Sortase-catalysed anchoring of surface proteins to the cell wall of Staphylococcus aureus. Mol Microbiol (2001) 3.39
The evolution of Staphylococcus aureus. Infect Genet Evol (2008) 3.18
A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB. J Bacteriol (2008) 2.51
Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J Infect Dis (2001) 2.34
A novel variant of the immunoglobulin fold in surface adhesins of Staphylococcus aureus: crystal structure of the fibrinogen-binding MSCRAMM, clumping factor A. EMBO J (2002) 2.06
Staphylococcal complement evasion by various convertase-blocking molecules. J Exp Med (2007) 2.03
Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence. Infect Immun (2005) 1.62
The fibrinogen-binding MSCRAMM (clumping factor) of Staphylococcus aureus has a Ca2+-dependent inhibitory site. J Biol Chem (1998) 1.59
Capsule production and growth phase influence binding of complement to Staphylococcus aureus. Infect Immun (2001) 1.59
Fibronectin-binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgammaRIIa receptor. Mol Microbiol (2006) 1.50
Ultrastructures and interactions of complement factors H and I. J Immunol (1992) 1.49
Incidence and characteristics of vancomycin nonsusceptible strains of methicillin-resistant Staphylococcus aureus at Hershey Medical Center. Antimicrob Agents Chemother (2008) 1.37
Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A. Mol Microbiol (2005) 1.37
Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b. J Infect Dis (2008) 1.30
Staphylococcus aureus Cap5O has UDP-ManNAc dehydrogenase activity and is essential for capsule expression. Infect Immun (2001) 1.30
Methicillin-resistant Staphylococcus aureus: A public health issue with economic consequences. Can J Infect Dis Med Microbiol (2007) 1.28
Fibrinogen and elastin bind to the same region within the A domain of fibronectin binding protein A, an MSCRAMM of Staphylococcus aureus. Mol Microbiol (2007) 1.26
Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes. FEMS Microbiol Lett (2006) 1.24
Availability of complement bound to Staphylococcus aureus to interact with membrane complement receptors influences efficiency of phagocytosis. Infect Immun (2003) 1.18
Fibrinogen binding sites P336 and Y338 of clumping factor A are crucial for Staphylococcus aureus virulence. PLoS One (2008) 1.14
Cleavage of complement C3b to iC3b on the surface of Staphylococcus aureus is mediated by serum complement factor I. Infect Immun (2004) 1.10
Emergence of SCCmec type IV as the most common type of methicillin-resistant Staphylococcus aureus in a university hospital. Infection (2008) 1.07
Inhibition of factor I by diisopropylfluorophosphate. Evidence of conformational changes in factor I induced by C3b and additional studies on the specificity of factor I. J Immunol (1990) 1.04
Hirudin versus heparin for use in whole blood in vitro biocompatibility models. J Biomed Mater Res A (2009) 1.01
Acute antibody-mediated complement activation mediates lysis of pancreatic islets cells and may cause tissue loss in clinical islet transplantation. Transplantation (2008) 1.00
Serum complement factor I decreases Staphylococcus aureus phagocytosis. J Lab Clin Med (2005) 0.88
A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB. J Bacteriol (2008) 2.51
Transforming the untransformable: application of direct transformation to manipulate genetically Staphylococcus aureus and Staphylococcus epidermidis. MBio (2012) 2.26
The interaction of bacterial pathogens with platelets. Nat Rev Microbiol (2006) 2.26
The role of Staphylococcus aureus surface protein SasG in adherence and biofilm formation. Microbiology (2007) 2.15
Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A. Mol Microbiol (2002) 2.02
Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonization. Cell Microbiol (2002) 2.02
Characterization of novel LPXTG-containing proteins of Staphylococcus aureus identified from genome sequences. Microbiology (2003) 1.98
The Staphylococcus aureus surface protein SasG and its homologues promote bacterial adherence to human desquamated nasal epithelial cells. Microbiology (2003) 1.86
Protein A-mediated multicellular behavior in Staphylococcus aureus. J Bacteriol (2008) 1.81
Sip, an integrase protein with excision, circularization and integration activities, defines a new family of mobile Staphylococcus aureus pathogenicity islands. Mol Microbiol (2003) 1.79
Staphylococcus aureus protein A activates TNFR1 signaling through conserved IgG binding domains. J Biol Chem (2006) 1.72
Alpha-toxin facilitates the generation of CXC chemokine gradients and stimulates neutrophil homing in Staphylococcus aureus pneumonia. J Infect Dis (2008) 1.68
Surface proteins that promote adherence of Staphylococcus aureus to human desquamated nasal epithelial cells. BMC Microbiol (2009) 1.68
Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus. J Infect Dis (2009) 1.62
Hypochlorite killing of community-associated methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J (2008) 1.53
Fibronectin-binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgammaRIIa receptor. Mol Microbiol (2006) 1.50
An improved tetracycline-inducible expression vector for Staphylococcus aureus. Plasmid (2008) 1.49
Interaction of human complement with Sbi, a staphylococcal immunoglobulin-binding protein: indications of a novel mechanism of complement evasion by Staphylococcus aureus. J Biol Chem (2008) 1.42
The N-terminal A domain of fibronectin-binding proteins A and B promotes adhesion of Staphylococcus aureus to elastin. J Biol Chem (2004) 1.42
Role of surface protein SasG in biofilm formation by Staphylococcus aureus. J Bacteriol (2010) 1.40
The elastin-binding protein of Staphylococcus aureus (EbpS) is expressed at the cell surface as an integral membrane protein and not as a cell wall-associated protein. J Biol Chem (2001) 1.37
Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A. Mol Microbiol (2005) 1.37
Expression of the biofilm-associated protein interferes with host protein receptors of Staphylococcus aureus and alters the infective process. Infect Immun (2002) 1.37
Clumping factor B, a fibrinogen-binding MSCRAMM (microbial surface components recognizing adhesive matrix molecules) adhesin of Staphylococcus aureus, also binds to the tail region of type I cytokeratin 10. J Biol Chem (2004) 1.36
Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b. J Infect Dis (2008) 1.30
Fibrinogen and elastin bind to the same region within the A domain of fibronectin binding protein A, an MSCRAMM of Staphylococcus aureus. Mol Microbiol (2007) 1.26
Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes. FEMS Microbiol Lett (2006) 1.24
Molecular characterization of the interaction of staphylococcal microbial surface components recognizing adhesive matrix molecules (MSCRAMM) ClfA and Fbl with fibrinogen. J Biol Chem (2009) 1.24
Genome sequence of Staphylococcus lugdunensis N920143 allows identification of putative colonization and virulence factors. FEMS Microbiol Lett (2011) 1.21
The Sbi protein is a multifunctional immune evasion factor of Staphylococcus aureus. Infect Immun (2011) 1.16
Staphylococcus aureus beta-toxin induces lung injury through syndecan-1. Am J Pathol (2009) 1.16
Nasal colonisation by Staphylococcus aureus depends upon clumping factor B binding to the squamous epithelial cell envelope protein loricrin. PLoS Pathog (2012) 1.16
Fibrinogen binding sites P336 and Y338 of clumping factor A are crucial for Staphylococcus aureus virulence. PLoS One (2008) 1.14
Human astrovirus coat protein binds C1q and MBL and inhibits the classical and lectin pathways of complement activation. Mol Immunol (2009) 1.14
Molecular basis for Staphylococcus aureus-mediated platelet aggregate formation under arterial shear in vitro. Arterioscler Thromb Vasc Biol (2007) 1.14
Staphylococcus aureus protein A binding to von Willebrand factor A1 domain is mediated by conserved IgG binding regions. FEBS J (2006) 1.13
Activation of syndecan-1 ectodomain shedding by Staphylococcus aureus alpha-toxin and beta-toxin. J Biol Chem (2003) 1.12
Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus. J Allergy Clin Immunol (2010) 1.12
Increased virulence of a fibronectin-binding protein mutant of Staphylococcus aureus in a rat model of pneumonia. Infect Immun (2002) 1.10
Structural and biochemical characterization of Staphylococcus aureus clumping factor B/ligand interactions. J Biol Chem (2011) 1.10
Iron-regulated surface determinant protein A mediates adhesion of Staphylococcus aureus to human corneocyte envelope proteins. Infect Immun (2009) 1.09
Human astrovirus coat protein inhibits serum complement activation via C1, the first component of the classical pathway. J Virol (2007) 1.05
Fibrinogen is a ligand for the Staphylococcus aureus microbial surface components recognizing adhesive matrix molecules (MSCRAMM) bone sialoprotein-binding protein (Bbp). J Biol Chem (2011) 1.05
Localized tufts of fibrils on Staphylococcus epidermidis NCTC 11047 are comprised of the accumulation-associated protein. J Bacteriol (2007) 1.04
beta-Neurexin is a ligand for the Staphylococcus aureus MSCRAMM SdrC. PLoS Pathog (2010) 1.04
Staphylococcal biofilm-forming protein has a contiguous rod-like structure. Proc Natl Acad Sci U S A (2012) 1.04
Identification of the Staphylococcus aureus MSCRAMM clumping factor B (ClfB) binding site in the alphaC-domain of human fibrinogen. Microbiology (2008) 1.03
Both complement- and fibrinogen-dependent mechanisms contribute to platelet aggregation mediated by Staphylococcus aureus clumping factor B. Infect Immun (2007) 1.02
Immune evasion by Staphylococcus aureus conferred by iron-regulated surface determinant protein IsdH. Microbiology (2009) 1.02
The role of Staphylococcus aureus adhesins in the pathogenesis of ventricular assist device-related infections. J Infect Dis (2006) 1.01
Staphylococcus lugdunensis IsdG liberates iron from host heme. J Bacteriol (2011) 1.01
Characterization of the fibrinogen-binding surface protein Fbl of Staphylococcus lugdunensis. Microbiology (2004) 1.00
FbsA, a fibrinogen-binding protein from Streptococcus agalactiae, mediates platelet aggregation. Blood (2004) 1.00
Iron-regulated surface determinant (Isd) proteins of Staphylococcus lugdunensis. J Bacteriol (2012) 0.99
Staphylococcus aureus protein A binds to osteoblasts and triggers signals that weaken bone in osteomyelitis. PLoS One (2011) 0.98
Staphylococcus aureus surface protein SdrE binds complement regulator factor H as an immune evasion tactic. PLoS One (2012) 0.97
Subdomains N2N3 of fibronectin binding protein A mediate Staphylococcus aureus biofilm formation and adherence to fibrinogen using distinct mechanisms. J Bacteriol (2013) 0.97
Corneal pathogenesis of Staphylococcus aureus strain Newman. Invest Ophthalmol Vis Sci (2002) 0.96
SdrF, a Staphylococcus epidermidis surface protein, binds type I collagen. J Biol Chem (2007) 0.96
Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein. Mol Immunol (2010) 0.95
Direct interaction of iron-regulated surface determinant IsdB of Staphylococcus aureus with the GPIIb/IIIa receptor on platelets. Microbiology (2009) 0.94
Fibronectin-binding proteins are required for biofilm formation by community-associated methicillin-resistant Staphylococcus aureus strain LAC. FEMS Microbiol Lett (2014) 0.94
Sequence diversity in the A domain of Staphylococcus aureus fibronectin-binding protein A. BMC Microbiol (2008) 0.94
Fibronectin-binding protein B variation in Staphylococcus aureus. BMC Microbiol (2010) 0.94
Nlrp-3-driven interleukin 17 production by γδT cells controls infection outcomes during Staphylococcus aureus surgical site infection. Infect Immun (2013) 0.93
Staphylococcus aureus protein A binding to osteoblast tumour necrosis factor receptor 1 results in activation of nuclear factor kappa B and release of interleukin-6 in bone infection. Microbiology (2012) 0.92
Capsular polysaccharide masks clumping factor A-mediated adherence of Staphylococcus aureus to fibrinogen and platelets. J Infect Dis (2007) 0.92
Staphylococcus aureus protein A plays a critical role in mediating bone destruction and bone loss in osteomyelitis. PLoS One (2012) 0.92
The binding force of the staphylococcal adhesin SdrG is remarkably strong. Mol Microbiol (2014) 0.92
Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus. J Transl Med (2012) 0.90
Genetic manipulation of Staphylococci-breaking through the barrier. Front Cell Infect Microbiol (2012) 0.89
Comparison of the mechanical properties of cellulose and starch films. Biomacromolecules (2010) 0.88
Sortase A promotes virulence in experimental Staphylococcus lugdunensis endocarditis. Microbiology (2013) 0.88
The N-terminal A domain of Staphylococcus aureus fibronectin-binding protein A binds to tropoelastin. Biochemistry (2007) 0.87
IsdC from Staphylococcus lugdunensis induces biofilm formation under low-iron growth conditions. Infect Immun (2014) 0.86
Analysis of mutations in the Staphylococcus aureus clfB promoter leading to increased expression. Microbiology (2003) 0.86
A novel peptide inhibitor of classical and lectin complement activation including ABO incompatibility. Mol Immunol (2012) 0.86
Functional blocking of Staphylococcus aureus adhesins following growth in ex vivo media. Infect Immun (2002) 0.86
SdrC induces staphylococcal biofilm formation through a homophilic interaction. Mol Microbiol (2014) 0.85
Phase-variable expression of the biofilm-associated protein (Bap) in Staphylococcus aureus. Microbiology (2007) 0.85
Role of molecular diagnostics in the management of infectious disease emergencies. Med Clin North Am (2012) 0.85
Ceftriaxone-induced hemolysis in a child with Lyme arthritis: a case for antimicrobial stewardship. Pediatrics (2011) 0.84
The immune evasion protein Sbi of Staphylococcus aureus occurs both extracellularly and anchored to the cell envelope by binding lipoteichoic acid. Mol Microbiol (2012) 0.84
The A domain of fibronectin-binding protein B of Staphylococcus aureus contains a novel fibronectin binding site. FEBS J (2011) 0.84
Complement regulator C4BP binds to Staphylococcus aureus and decreases opsonization. Mol Immunol (2012) 0.84
Staphylococcus pseudintermedius expresses surface proteins that closely resemble those from Staphylococcus aureus. Vet Microbiol (2009) 0.83
Complement inhibition significantly decreases red blood cell lysis in a rat model of acute intravascular hemolysis. Transfusion (2014) 0.82